Sílvia Quadrelli

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 522 citations · Full text

Inbuild Trial, Parallel-group Trial, Advanced Lung Disease +5

Follow-up and Surveillance of the Patient With Lung Cancer After Curative-Intent Therapy

Henri G. Colt, Septimiu Murgu, Robert J. Korst et al. · CHEST Journal · 2013 · 224 citations · Full text

Oncology, Advanced Lung Disease, Curative-intent Therapy +8

Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer

M. Castro, Laura Grau, Patricia Puerta et al. · Journal of Translational Medicine · 2010 · 129 citations · Full text

Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation

Michael Kreuter, Markus Polke, Simon Walsh et al. · European Respiratory Journal · 2020 · 98 citations · Full text

High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study

Sujal R. Desai, Nishanth Sivarasan, Kerri A. Johannson et al. · The Lancet Respiratory Medicine · 2023 · 57 citations · Full text

Health Sciences, Medical Imaging, Advanced Lung Disease +9